CHIROFLU

This brand name is authorized in Spain

Active ingredients

The drug CHIROFLU contains a combination of these active pharmaceutical ingredients (APIs):

1 A/Victoria/2570/2019 (H1N1)pdm09 (A/Victoria/2570/2019 IVR-215)
Read about Influenza, inactivated, surface antigen
2 A/Cambodia/e0826360/2020 (H3N2) (A/Cambodia/e0826360/2020 IVR-224)
Read about Influenza, inactivated, surface antigen
3 B/Washington/02/2019 (B/Victoria/705/2018 BVR-11)
Read about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62792

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.